Europe Parenteral Lipid Emulsion Market Size, Share & Trends Analysis Report By Ingredient (1st Generation Lipid Emulsions, 2nd Generation Lipid Emulsions, 3rd Generation Lipid Emulsions), By Country, And Segment Forecasts, 2023 - 2030
This report can be delivered to the clients within 2 Business Days
Europe Parenteral Lipid Emulsion Market Growth & Trends
The Europe parenteral lipid emulsion market size is projected to reach USD 1.04 billion by 2030 and is anticipated to expand at a CAGR of 6.3% over the forecast period, according to a new report by Grand View Research, Inc. Growing burden of chronic diseases, such as diabetes, cancer, other neurological conditions; increasing deficiency of essential fatty acids among critically ill patients; and growing awareness regarding hospital-related malnutrition are some of the major factors driving the adoption of lipid emulsions. Parenteral lipid emulsions play a vital role in supporting better health outcomes, as malnutrition can have a serious impact on hospitalized patients. Hospitalized adults diagnosed with malnutrition have a longer length of hospital stay and higher recovery costs and are five times more likely to die as compared to other adult inpatients. Therefore, intravenous fat emulsions are used for preventing or reversing fatty acid deficiency by providing a source of calories to patients with urgent n
ed for parenteral nutrition.
The adoption of parenteral nutrition is increasing among the geriatric group, as they are unable to fulfill their nutritional requirements through the enteral route. There is an inverse relationship between nutritional status and complications associated with the length of stay in the hospital and the time to recover after an acute illness among the elderly patient group. The growing geriatric population, surge in demand for fat emulsions among critically ill patients for fulfilling their nutritional requirements, and high prevalence of chronic diseases, including Alzheimer’s, inflammatory bowel disease, and others, are key factors responsible for higher adoption of parenteral lipid emulsions among this patient population.
Furthermore, an increase in the number of strategic initiatives undertaken by leading manufacturers to expand their footprint and product reach is expected to drive the market. Significant investments, the setup of new product lines, and various research initiatives for the development of new lipid emulsions are anticipated to boost the market growth. For instance, in July 2019, Baxter announced the European launch of Finomel to its parenteral nutrition portfolio. Moreover, increasing approvals for innovative products, including hybrid lipid emulsions with a combination of two or more sources such as soybean and olive oil, are likely to fuel market growth.
Europe Parenteral Lipid Emulsion Market Report Highlights
Europe Parenteral Lipid Emulsion Market Growth & Trends
The Europe parenteral lipid emulsion market size is projected to reach USD 1.04 billion by 2030 and is anticipated to expand at a CAGR of 6.3% over the forecast period, according to a new report by Grand View Research, Inc. Growing burden of chronic diseases, such as diabetes, cancer, other neurological conditions; increasing deficiency of essential fatty acids among critically ill patients; and growing awareness regarding hospital-related malnutrition are some of the major factors driving the adoption of lipid emulsions. Parenteral lipid emulsions play a vital role in supporting better health outcomes, as malnutrition can have a serious impact on hospitalized patients. Hospitalized adults diagnosed with malnutrition have a longer length of hospital stay and higher recovery costs and are five times more likely to die as compared to other adult inpatients. Therefore, intravenous fat emulsions are used for preventing or reversing fatty acid deficiency by providing a source of calories to patients with urgent n
ed for parenteral nutrition.
The adoption of parenteral nutrition is increasing among the geriatric group, as they are unable to fulfill their nutritional requirements through the enteral route. There is an inverse relationship between nutritional status and complications associated with the length of stay in the hospital and the time to recover after an acute illness among the elderly patient group. The growing geriatric population, surge in demand for fat emulsions among critically ill patients for fulfilling their nutritional requirements, and high prevalence of chronic diseases, including Alzheimer’s, inflammatory bowel disease, and others, are key factors responsible for higher adoption of parenteral lipid emulsions among this patient population.
Furthermore, an increase in the number of strategic initiatives undertaken by leading manufacturers to expand their footprint and product reach is expected to drive the market. Significant investments, the setup of new product lines, and various research initiatives for the development of new lipid emulsions are anticipated to boost the market growth. For instance, in July 2019, Baxter announced the European launch of Finomel to its parenteral nutrition portfolio. Moreover, increasing approvals for innovative products, including hybrid lipid emulsions with a combination of two or more sources such as soybean and olive oil, are likely to fuel market growth.
Europe Parenteral Lipid Emulsion Market Report Highlights
- 1st generation lipid emulsions dominated the market in 2022 owing to the increasing geriatric population and growing burden of non-communicable diseases on healthcare. Also, these lipid emulsion formulation has witnessed a significant demand as it has found its way into lipid rescue during anesthesia toxicity
- Germany dominated the market in 2022 due to a surge in demand from critically ill patients and high prevalence of chronic diseases in the country
CHAPTER 1. METHODOLOGY AND SCOPE
1.1 Research Scope and Assumptions
1.1.1 Country Level Market Size Estimates
1.2 Grand View Research Survey Methodology
1.3 List to Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Europe Parenteral Lipid Emulsion Market Snapshot
2.2 Competitive Landscape Snapshot
CHAPTER 3. EUROPE PARENTERAL LIPID EMULSION MARKET VARIABLES, TRENDS AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing incidence of hospital malnutrition
3.2.1.2 Rising prevalence of cancer
3.2.1.3 Increasing incidence of gastrointestinal disease
3.2.1.4 Rising geriatric population
3.2.2 Market Restraint Analysis
3.2.2.1 Risk of infection
3.2.2.2 Shortage of parenteral lipid emulsion products
3.2.3 Industry Challenges
3.2.3.1 Increased use of Enteral Nutrition (EN)
3.2.3.2 Lack of standardization in parenteral nutrition practices and guidelines
3.3 Europe Parenteral Lipid Emulsion Market Analysis Tools
3.3.1 Europe Parenteral Lipid Emulsion Market - Pestle Analysis
3.3.2 Industry Analysis - Porter’s
3.4 Impact of COVID-19 Pandemic on the Europe Parenteral Lipid Emulsion Market
3.5 Parenteral Nutrition: Reimbursement Framework
CHAPTER 4. EUROPE PARENTERAL LIPID EMULSION MARKET: PRICING ANALYSIS
4.1 Europe Parenteral Lipid Emulsion Market: Pricing Analysis
4.1.1 Pricing Analysis For Parenteral Lipid Emulsion Products
4.1.2 Annual Cost For Patients, 2022
4.1.3 Annual Cost For Hospitals, 2022
CHAPTER 5. EUROPE PARENTERAL LIPID EMULSION MARKET: INGREDIENTS ESTIMATES AND TREND ANALYSIS
5.1 Europe Parenteral Lipid Emulsion Market: Overview
5.1.1 1st Generation: Mct (Soybean Oil)
5.1.1.1 Overview
5.1.1.2 Composition
5.1.1.3 Penetration Analysis: Analyst Perspective
5.1.2 2nd Generation: Mct (Coconut Oil) And Lct (Olive Oil)
5.1.2.1 Overview
5.1.2.2 Composition
5.1.2.3 Penetration Analysis: Analyst Perspective
5.1.3 3rd Generation: Smof (Fish Oil)
5.1.3.1 Overview
5.1.3.2 Composition
5.1.3.3 Penetration Analysis: Analyst Perspective
CHAPTER 6. EUROPE PARENTERAL LIPID EMULSION MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Europe Parenteral Lipid Emulsion market: Country Movement Analysis, 2022 & 2030 (USD Million)
6.2. Europe Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.3. UK
6.3.1. Key Country Dynamics
6.3.2. Competitive Scenario
6.3.3. Regulatory Framework
6.3.4. Reimbursement Scenario
6.3.5. UK Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Germany
6.4.1. Key Country Dynamics
6.4.2. Competitive Scenario
6.4.3. Regulatory Framework
6.4.4. Reimbursement Scenario
6.4.5. Germany Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.5. France
6.5.1. Key Country Dynamics
6.5.2. Competitive Scenario
6.5.3. Regulatory Framework
6.5.4. Reimbursement Scenario
6.5.5. France Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Italy
6.6.1. Key Country Dynamics
6.6.2. Competitive Scenario
6.6.3. Regulatory Framework
6.6.4. Reimbursement Scenario
6.6.5. Italy Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.7. Spain
6.7.1. Key Country Dynamics
6.7.2. Competitive Scenario
6.7.3. Regulatory Framework
6.7.4. Reimbursement Scenario
6.7.5. Spain Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Belgium
6.8.1. Key Country Dynamics
6.8.2. Competitive Scenario
6.8.3. Regulatory Framework
6.8.4. Reimbursement Scenario
6.8.5. Belgium Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.9. Austria
6.9.1. Key Country Dynamics
6.9.2. Competitive Scenario
6.9.3. Regulatory Framework
6.9.4. Reimbursement Scenario
6.9.5. Austria Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.10. Ireland
6.10.1. Key Country Dynamics
6.10.2. Competitive Scenario
6.10.3. Regulatory Framework
6.10.4. Reimbursement Scenario
6.10.5. Ireland Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.11. Poland
6.11.1. Key Country Dynamics
6.11.2. Competitive Scenario
6.11.3. Regulatory Framework
6.11.4. Reimbursement Scenario
6.11.5. Poland Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.12. Czech Republic
6.12.1. Key Country Dynamics
6.12.2. Competitive Scenario
6.12.3. Regulatory Framework
6.12.4. Reimbursement Scenario
6.12.5. Czech Republic Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVELANDSCAPE
7.1 Company Categorization
7.2. Key Company Market Position Analysis
7.3. Key Company Market Share Analysis
7.4. Recent Developments & Impact Analysis, By Key Market Participants Company Profiles/Listing
7.4.1. Baxter
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Braun Melsungen AG
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Fresenius SE & Co. KGaA
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Grifols S.A.
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
1.1 Research Scope and Assumptions
1.1.1 Country Level Market Size Estimates
1.2 Grand View Research Survey Methodology
1.3 List to Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1 Europe Parenteral Lipid Emulsion Market Snapshot
2.2 Competitive Landscape Snapshot
CHAPTER 3. EUROPE PARENTERAL LIPID EMULSION MARKET VARIABLES, TRENDS AND SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing incidence of hospital malnutrition
3.2.1.2 Rising prevalence of cancer
3.2.1.3 Increasing incidence of gastrointestinal disease
3.2.1.4 Rising geriatric population
3.2.2 Market Restraint Analysis
3.2.2.1 Risk of infection
3.2.2.2 Shortage of parenteral lipid emulsion products
3.2.3 Industry Challenges
3.2.3.1 Increased use of Enteral Nutrition (EN)
3.2.3.2 Lack of standardization in parenteral nutrition practices and guidelines
3.3 Europe Parenteral Lipid Emulsion Market Analysis Tools
3.3.1 Europe Parenteral Lipid Emulsion Market - Pestle Analysis
3.3.2 Industry Analysis - Porter’s
3.4 Impact of COVID-19 Pandemic on the Europe Parenteral Lipid Emulsion Market
3.5 Parenteral Nutrition: Reimbursement Framework
CHAPTER 4. EUROPE PARENTERAL LIPID EMULSION MARKET: PRICING ANALYSIS
4.1 Europe Parenteral Lipid Emulsion Market: Pricing Analysis
4.1.1 Pricing Analysis For Parenteral Lipid Emulsion Products
4.1.2 Annual Cost For Patients, 2022
4.1.3 Annual Cost For Hospitals, 2022
CHAPTER 5. EUROPE PARENTERAL LIPID EMULSION MARKET: INGREDIENTS ESTIMATES AND TREND ANALYSIS
5.1 Europe Parenteral Lipid Emulsion Market: Overview
5.1.1 1st Generation: Mct (Soybean Oil)
5.1.1.1 Overview
5.1.1.2 Composition
5.1.1.3 Penetration Analysis: Analyst Perspective
5.1.2 2nd Generation: Mct (Coconut Oil) And Lct (Olive Oil)
5.1.2.1 Overview
5.1.2.2 Composition
5.1.2.3 Penetration Analysis: Analyst Perspective
5.1.3 3rd Generation: Smof (Fish Oil)
5.1.3.1 Overview
5.1.3.2 Composition
5.1.3.3 Penetration Analysis: Analyst Perspective
CHAPTER 6. EUROPE PARENTERAL LIPID EMULSION MARKET: COUNTRY ESTIMATES & TREND ANALYSIS
6.1. Europe Parenteral Lipid Emulsion market: Country Movement Analysis, 2022 & 2030 (USD Million)
6.2. Europe Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.3. UK
6.3.1. Key Country Dynamics
6.3.2. Competitive Scenario
6.3.3. Regulatory Framework
6.3.4. Reimbursement Scenario
6.3.5. UK Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Germany
6.4.1. Key Country Dynamics
6.4.2. Competitive Scenario
6.4.3. Regulatory Framework
6.4.4. Reimbursement Scenario
6.4.5. Germany Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.5. France
6.5.1. Key Country Dynamics
6.5.2. Competitive Scenario
6.5.3. Regulatory Framework
6.5.4. Reimbursement Scenario
6.5.5. France Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Italy
6.6.1. Key Country Dynamics
6.6.2. Competitive Scenario
6.6.3. Regulatory Framework
6.6.4. Reimbursement Scenario
6.6.5. Italy Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.7. Spain
6.7.1. Key Country Dynamics
6.7.2. Competitive Scenario
6.7.3. Regulatory Framework
6.7.4. Reimbursement Scenario
6.7.5. Spain Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.8. Belgium
6.8.1. Key Country Dynamics
6.8.2. Competitive Scenario
6.8.3. Regulatory Framework
6.8.4. Reimbursement Scenario
6.8.5. Belgium Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.9. Austria
6.9.1. Key Country Dynamics
6.9.2. Competitive Scenario
6.9.3. Regulatory Framework
6.9.4. Reimbursement Scenario
6.9.5. Austria Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.10. Ireland
6.10.1. Key Country Dynamics
6.10.2. Competitive Scenario
6.10.3. Regulatory Framework
6.10.4. Reimbursement Scenario
6.10.5. Ireland Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.11. Poland
6.11.1. Key Country Dynamics
6.11.2. Competitive Scenario
6.11.3. Regulatory Framework
6.11.4. Reimbursement Scenario
6.11.5. Poland Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
6.12. Czech Republic
6.12.1. Key Country Dynamics
6.12.2. Competitive Scenario
6.12.3. Regulatory Framework
6.12.4. Reimbursement Scenario
6.12.5. Czech Republic Parenteral Lipid Emulsion Market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVELANDSCAPE
7.1 Company Categorization
7.2. Key Company Market Position Analysis
7.3. Key Company Market Share Analysis
7.4. Recent Developments & Impact Analysis, By Key Market Participants Company Profiles/Listing
7.4.1. Baxter
7.4.1.1. Overview
7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Braun Melsungen AG
7.4.2.1. Overview
7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Fresenius SE & Co. KGaA
7.4.3.1. Overview
7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. Grifols S.A.
7.4.4.1. Overview
7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Europe parenteral lipid emulsion market, by country, 2018 - 2030 (USD Million)
Table 4 Europe parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 5 Europe parenteral lipid emulsion market, by formulation, 2018 - 2030 (USD Million)
Table 6 Europe parenteral lipid emulsion market, by sales channel, 2018 - 2030 (USD Million)
Table 7 UK parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 8 Germany parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 9 Italy parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 10 Spain parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 11 France parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 12 Austria parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 13 Belgium parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 14 Ireland parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 15 Poland parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 16 Czech Republic parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Europe parenteral lipid emulsion market, by country, 2018 - 2030 (USD Million)
Table 4 Europe parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 5 Europe parenteral lipid emulsion market, by formulation, 2018 - 2030 (USD Million)
Table 6 Europe parenteral lipid emulsion market, by sales channel, 2018 - 2030 (USD Million)
Table 7 UK parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 8 Germany parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 9 Italy parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 10 Spain parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 11 France parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 12 Austria parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 13 Belgium parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 14 Ireland parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 15 Poland parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
Table 16 Czech Republic parenteral lipid emulsion market, by ingredients, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Parenteral lipid emulsion market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Parenteral lipid emulsion market summary, 2022 (USD Million)
Fig. 6 Parenteral lipid emulsion market trends & outlook
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 Parenteral lipid emulsion market, ingredient outlook key takeaways (USD Million)
Fig. 10 Parenteral lipid emulsion market: ingredient movement analysis (USD Million), 2022 & 2030
Fig. 11 1st generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 12 2nd generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 3rd generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Regional marketplace: Key takeaways
Fig. 15 Europe parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 UK parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Germany parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 France parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Spain parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Italy parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Austria parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Belgium parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Ireland parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Poland parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Czech Republic parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Parenteral lipid emulsion market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Parenteral lipid emulsion market summary, 2022 (USD Million)
Fig. 6 Parenteral lipid emulsion market trends & outlook
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 Parenteral lipid emulsion market, ingredient outlook key takeaways (USD Million)
Fig. 10 Parenteral lipid emulsion market: ingredient movement analysis (USD Million), 2022 & 2030
Fig. 11 1st generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 12 2nd generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 13 3rd generation lipid emulsions market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Regional marketplace: Key takeaways
Fig. 15 Europe parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 UK parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Germany parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 France parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Spain parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Italy parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Austria parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Belgium parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Ireland parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Poland parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Czech Republic parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
